Skip to main content
Clinical Trials/NL-OMON52454
NL-OMON52454
Recruiting
Not Applicable

The effects of antipsychotic maintenance therapy on brain volume: randomized (dis)continuation after remission of a first psychotic episode. - HAMLETT MRI

niversitair Medisch Centrum Groningen0 sites225 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psychotic disorder / Schizophrenia
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
225
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for FEP patients:
  • 1\. The participant has had a first episode of psychosis and uses antipsychotic
  • medication.
  • 2\. Psychotic symptoms are in remission for 3\-6 months with an antipsychotic.
  • 3\. Age 18\-60 years.
  • 4\. The participant understands the study and is able to provide written
  • informed consent.
  • 5\. HAMLETT is the only medical\-scientific medication study in which the patient
  • participates.
  • 6\. Sufficient command of the Dutch language.

Exclusion Criteria

  • Exclusion criteria for FEP patients:
  • 1\. Dangerous or harmful behaviour occurred during the psychosis
  • 2\. Coercive treatment (based on judicial ruling)
  • 3\. The refusal to be informed of structural brain abnormalities that could be
  • detected during the experiment
  • 4\. MRI contra\-indications, e.g. Ferrous objects in or around the body, or
  • claustrophobia
  • 5\. Pregnancy
  • Exclusion criteria for healthy controls for the OCT\-scan:
  • 1\. (History of) diagnosed psychiatric disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials